Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -19.16% | 10.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.16% | 10.60% | |||
| Cost of Revenue | -26.67% | 10.45% | |||
| Gross Profit | -14.55% | 10.69% | |||
| SG&A Expenses | 14.88% | -12.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.20% | -10.32% | |||
| Operating Income | -22.58% | 16.95% | |||
| Income Before Tax | -241.64% | 126.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -241.64% | 126.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -241.64% | 126.31% | |||
| EBIT | -22.58% | 16.95% | |||
| EBITDA | -22.93% | 17.34% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | 0.95% | 0.86% | |||
| Average Diluted Shares Outstanding | -79.28% | 391.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||